GlassScriptPhysician profile
Jacqueline S Turner
NPI 1447209671
$1,647.19
in general payments reported to CMS, 2019-2025
22 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $177 · 2021: $234 · 2024: $112 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.45 | 2019-2021 | |
| Therapeuticsmd, INC. | $159.31 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $153.71 | 2019-2021 | |
| Viiv Healthcare Company | $112.26 | 2024 | |
| Radius Health, INC. | $104.03 | 2025 | Tymlos |
| Merck Sharp & Dohme LLC | $100.01 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $94.58 | 2019 | |
| Roche Diagnostics Corporation | $92.08 | 2019 | |
| Gilead Sciences, INC. | $83.90 | 2019 | |
| Exeltis, USA INC. | $44.59 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $34.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.31 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.38 | 2019 | |
| Agile Therapeutics, INC. | $26.88 | 2021 | |
| Lupin INC. | $24.16 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $22.44 | 2021 | |
| Karl Storz Endoscopy-America | $22.08 | 2020 | |
| Daiichi Sankyo INC. | $20.46 | 2021 | |
| Avion Pharmaceuticals | $18.68 | 2021 | |
| Evofem Biosciences, INC. | $13.75 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.69 | 2019 | |
| Coopersurgical, INC. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.